Why Do I Feel Cold After Taking Mounjaro: Causes and Relief

Last reviewed: July 14, 2026

Last updated: July 14, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, works by slowing gastric emptying and reducing hunger signals in the brain—but these same mechanisms can alter how your body regulates temperature. Feeling cold after starting tirzepatide is a real and often temporary side effect that affects a subset of patients, particularly in the first 4–8 weeks of treatment.

How Tirzepatide Affects Body Temperature Regulation

Tirzepatide influences your hypothalamus, the brain region controlling thermoregulation alongside appetite control. When GLP-1 and GIP pathways activate, your basal metabolic rate can dip slightly as your body adapts to reduced caloric intake. This metabolic shift doesn't mean you're gaining fat; rather, your body is conserving energy during the initial weight loss phase, which some people experience as pronounced chilliness or sensitivity to cold air.

The cold sensation is not dangerous on its own. Clinical trials show that thermogenic side effects resolve in most patients within 4–12 weeks as your metabolism stabilizes. However, if you're already lean or have low body fat, you may feel cold more acutely because you have less insulating fat tissue. Understanding this mechanism helps you recognize the symptom as a sign your medication is working, not a reason to stop treatment without medical guidance.

Why Cold Sensitivity Develops in Early Treatment Weeks

During the first month of tirzepatide therapy, your appetite suppression kicks in rapidly. When calorie intake drops significantly—especially if it drops faster than your body expects—your body may temporarily lower its core temperature set point. This is an evolutionary survival mechanism: reduced food availability historically signaled the need to conserve heat and energy. Your sympathetic nervous system responds by constricting blood vessels, pulling warmth from your extremities toward your core.

Weight loss itself accelerates heat loss. Fat tissue acts as insulation; as you lose weight, you lose that thermal buffer. Studies on rapid weight loss show that people can experience a 0.5–1.0°C drop in core body temperature during aggressive caloric restriction. PlexusDx tirzepatide patients often see rapid initial weight loss, so the combination of medication-driven appetite suppression plus actual fat loss can amplify cold sensations in weeks 2–6 of treatment.

Evidence-Based Strategies to Manage Tirzepatide-Related Chills

Layering clothing is the first-line approach: wear breathable base layers, sweaters, and jackets that you can remove if your body temperature normalizes later in the day. Avoid heavy single garments that trap too much heat and risk overheating during activity. Increase your warm beverage intake—herbal teas, warm water, and low-calorie broths raise internal temperature without adding significant calories and support hydration during weight loss.

Ensure adequate protein intake at each meal. Protein has the highest thermic effect of all macronutrients, meaning your body burns more calories digesting it and generates more heat in the process. Aim for 25–35g of protein per eating occasion to maintain muscle mass and promote thermogenesis. Light to moderate exercise, including walking and resistance training, increases metabolic heat production and counteracts the cold sensitivity many patients report. Avoid intense exercise on days when you feel particularly cold, as sweating followed by rapid heat loss can worsen chills.

Check your bedroom temperature and sleep environment. A slightly warmer room (68–72°F instead of 65°F) can help you sleep better and reduce nighttime chills without overdressing. If cold feelings persist beyond 12 weeks or worsen, contact your PlexusDx provider to review your dose and overall metabolic status. Rarely, excessive cold sensation may warrant a dose adjustment or medication switch.

When to Contact Your Provider About Tirzepatide-Related Cold Sensations

Most patients tolerate tirzepatide-related chills as a temporary, manageable side effect. However, you should reach out to your healthcare provider if you experience severe, uncontrollable shivering; persistent cold sensations after 16 weeks of stable dosing; or cold feelings accompanied by confusion, dizziness, or unusual fatigue—these could signal an underlying issue unrelated to tirzepatide. Your provider may order basic labs to rule out thyroid dysfunction or other metabolic concerns that could magnify temperature sensitivity.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is feeling cold after tirzepatide normal, or should I be worried?

Feeling cold is a common, temporary side effect of tirzepatide reported in clinical trials and is not dangerous on its own. The sensation typically resolves within 4–12 weeks as your body acclimates to the medication and your weight stabilizes. If chills persist beyond 16 weeks, intensify, or occur with other worrying symptoms, contact your PlexusDx provider for evaluation.

How long does tirzepatide-induced cold sensitivity usually last?

Most patients report that cold sensations peak in weeks 2–6 and gradually improve by week 8–12. Some experience lasting mild sensitivity if they achieve significant weight loss, because reduced body fat provides less natural insulation. Layering clothes and maintaining adequate protein intake can help manage the symptom throughout your treatment.

Can I adjust my tirzepatide dose if I'm too cold?

Do not adjust your tirzepatide dose on your own. Your PlexusDx provider monitors your response and will discuss dose timing or adjustments if side effects interfere with your quality of life. In rare cases, switching to a different compound like semaglutide may reduce cold sensitivity while maintaining weight loss benefits.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including your GLP1R and GIPR variants, to estimate how robustly you'll respond to tirzepatide. Patients with certain genetic profiles may experience faster appetite suppression and greater metabolic shifts, which can amplify early temperature sensitivity. Genetic data helps your provider anticipate side effects and personalize your treatment plan.

How much does tirzepatide cost at PlexusDx, and is it covered by insurance?

PlexusDx Compounded Tirzepatide Injection is $289/mo month-to-month (or $249/mo on the 6-month plan) with no insurance required and no membership fee. Your dose may need to go up. Your price won't. PlexusDx serves all 50 states and accepts HSA/FSA funds. After your first month, you can add the Precision Peptide Genetic Test for $99 to refine your personalized treatment strategy.

Related Reading

• What Are The Causes Of Ear Pain And How Can You Achieve Relief
• Causes Of Cold Intolerance And Effective Symptom Management
• Why Do I Feel Tired After Eating Is It In My Genes
• Can A Genetic Test Help Explain Why I Feel Tired All The Time

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.